The Electrospinning Company will be exhibiting at 3D Cell Culture 2014 - Advanced Model Systems, Applications & Enabling Technologies June 25, 2014 - June 27, 2014, Konzerthaus Freiburg Physiological relevance is a key parameter to improve predictivity of cell-based assays in drug discovery and toxicity testing for compound. The continually rising numbers of compound failures and increasing costs of drug and substance development are fostering the use of biologically more complex cell models from target identification to safety testing in substance development. Conventional 2D culture conditions are highly limited as native tissue morphology and cell composition is not properly reflected. To create tissue-specific structures and function in vitro, cell models have to be translated into the third dimension. Therefore, 3D cell culture technologies and associated analytical tools are essential for basic and pharmaceutical research as well as for the evaluation of chemicals and cosmetics. The symposium covers the newest developments in the key areas of 3D cell culture technologies. This comprises advanced 3D cell culture models for efficacy and safety studies, enabling technologies to create and analyze biological reactions as well as their successful implementation in compound de-risking. We look forward to meeting you in Freiburg! For conference details click here
Horizons in Human Cells Incorporating the 6th Quasi-Vivo® Users group.
Research & Innovation - Impact into Cancer - 2014 Come and meet us at stand IZ2 in the Innovation Zone to learn more about our 96 well plate containing the Mimetix scaffold for reproducible 3D cell culture.
Ann Kramer will be speaking on "Consistent electrospun fibres for reproducible 3D cell performance" at Nanofibres to Nanocomposites III in Nottingham Biocity on 27th February 2014. More details on the event can be found in the attached flyer. Nanofibres2014_Flyer_vr2